{
    "paper_id": "PMC7087949",
    "metadata": {
        "title": "Acyclic nucleoside phosphonates containing the amide bond: hydroxy derivatives",
        "authors": [
            {
                "first": "Iwona",
                "middle": [
                    "E."
                ],
                "last": "G\u0142owacka",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dorota",
                "middle": [
                    "G."
                ],
                "last": "Piotrowska",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Graciela",
                "middle": [],
                "last": "Andrei",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "Schols",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Snoeck",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Andrzej",
                "middle": [
                    "E."
                ],
                "last": "Wr\u00f3blewski",
                "suffix": "",
                "email": "andrzej.wroblewski@umed.lodz.pl",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Despite numerous efforts, highly effective antiviral drugs without side effects are not yet available. A search for such compounds appeared even more difficult, since various viruses can undergo fast mutations. Several antiviral medications are at physicians disposal and among them acyclic nucleoside phosphonates (ANPs) belong to the most important [1\u20133].",
            "cite_spans": [
                {
                    "start": 352,
                    "end": 353,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 354,
                    "end": 355,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Formulations delivering adefovir (1), tenofovir (2), (S)-HMPA (3), and cidofovir (4) (Fig. 1) have been used for several decades and their structural frameworks stimulated chemists to create modifications that are more active. Linkers connecting nucleobase and phosphonic acid moieties in 1\u20134 seem to be the first choice for modifications but this approach so far did not lead to discovery of more active compounds.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 91,
                    "end": 92,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Based on the commonly accepted mechanism of action of ANPs [3, 4], a structure of new analogs has to contain at both termini a P(O)\u2013CH2 fragment which is responsible for the stability towards phosphate-cleaving enzymes and nucleobases or their close analogs which facilitate interactions with nucleobases of viral nucleic acids. Preferably, a four-atom linker capable of hydrogen bonding should interconnect these units.",
            "cite_spans": [
                {
                    "start": 60,
                    "end": 61,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 63,
                    "end": 64,
                    "mention": "4",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Recently, we put forward an idea of replacing a P\u2013CH2\u2013O\u2013CHR\u2013 fragment in 1\u20134 with the amide bond [5]. This was inspired by the successful application of the isosteric replacement of this bond by a methylene ether [\u2013CH2\u2013O] moiety in studies on the biological activity of natural peptides [6\u20138]. However, the introduction of the amide [P\u2013CH2\u2013HN\u2013C(O)\u2013] residue significantly increases donor\u2013acceptor interactions within a new linker. It also modifies its conformational flexibility due to the restricted rotation around the amide bond. In our first approach [5], four series of the phosphonate amides of general formulae 5 and 6 were synthesized (Fig. 2).",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 99,
                    "mention": "5",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 288,
                    "end": 289,
                    "mention": "6",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 290,
                    "end": 291,
                    "mention": "8",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 556,
                    "end": 557,
                    "mention": "5",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 649,
                    "end": 650,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "In this paper, we continue our efforts to identify structural features in acyclic nucleoside phosphonates containing the amide bond 7\u20139 responsible for their antiviral activity. The phosphonates 5 and 6 containing the aliphatic linkages X (CH2, CH2CH2, and CH2CH2CH2) or ethereal interconnection (CH2OCH2CH2) including the methylene group which secured the separation of nitrogen atoms (N1 or N9) in nucleobases and the phosphorus atom by four bonds and resulted in compounds structurally closest to the drugs 1\u20134 that appeared inactive. Hence, we reasoned that installation of additional polar functionalities in the aliphatic linker could improve acyclic nucleoside\u2013enzyme interactions, and thus significantly increase the activity. Herein, we wish to describe our studies on the synthesis and the biological activity of the new amides 7\u20139 having the hydroxy groups within the aliphatic linker. To synthesize the final acyclic nucleoside phosphonates 7\u20139, the approach involving the formation of the amide bond between the respective acetic acid derivatives 13a\u201313h and \u03c9-aminophosphonates 10\u201312 was followed (Scheme 1) [5].",
            "cite_spans": [
                {
                    "start": 1123,
                    "end": 1124,
                    "mention": "5",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 1119,
                    "end": 1120,
                    "mention": "1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "For many years, the biological activity of phosphonate nucleoside analogs has been studied employing free phosphonic acids but recently, they are administered in the form of prodrugs (esters or amides) to significantly improve bioavailability of very polar acids [2, 3, 9\u201312]. We opted to test phosphonate diethyl esters 7\u20139, since they to some extent resemble the lipophilic prodrugs in ability to permeable cell membranes. Our recent experience is in line with this strategy as we discovered examples of the biologically active phosphonate diethyl esters substituted with various heterocyclic motives, while the respective free acids appeared inactive [13, 14].",
            "cite_spans": [
                {
                    "start": 264,
                    "end": 265,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 267,
                    "end": 268,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 270,
                    "end": 271,
                    "mention": "9",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 272,
                    "end": 274,
                    "mention": "12",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 655,
                    "end": 657,
                    "mention": "13",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 659,
                    "end": 661,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Furthermore, we were afraid of possible dehydration of our hydroxyalkylphosphonates under harsh conditions associated with the application of, for example, acids, bases or even iodotrimethylsilane.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "We were also interested in the conformational mobility of the amides 7a\u20137h to 9a\u20139h within new acyclic linkers to provide important information regarding structure\u2013activity analysis. Since 1H NMR spectra of all nucleotide analogs 7a\u20137h exhibited almost identical patterns regarding a P\u2013CH(OH)\u2013CH2\u2013NHC(O)\u2013CH2 fragment, we concluded that in a methanolic solution they exist in the same conformation. Detailed analysis of a 1H NMR spectrum of 7d, including a 1H{31P} one, clearly revealed an antiperiplanar disposition of the phosphoryl and amide groups projected as 18 (Fig. 4). Vicinal couplings H1\u2013H2a (3.6 Hz) and H1\u2013H2b (9.2 Hz) fit well into the ranges expected for the gauche and antiperiplanar arrangement of these protons [30]. Furthermore, values of both 3J(P\u2013H2a/H2b) coupling constants are close (7.2 and 8.5 Hz). These values were well correlated with those characteristic of the gauche hydrogen\u2013phosphorus relationship [31, 32]. The stability of the conformation 18 primarily results from the steric bulkiness of the substituents at C1 and C2 but may also be enforced by a C2\u2013N\u2013H\u00b7\u00b7\u00b7\u00b7\u00b7\u00b7\u00b7O(H)\u2013C1 hydrogen bond within a five-membered ring as depicted in 19 (Fig. 4). This suggestion finds support in a large downfield shift of the H2a proton (3.73 ppm) as compared with the H2b proton (3.38 ppm) which can only be observed when an amide C=O acts as a deshielding group. This is only possible when a C2\u2013N\u2013H\u00b7\u00b7\u00b7\u00b7\u00b7\u00b7\u00b7O(H)\u2013C1 hydrogen bond is strong enough to enable a free rotation around a C2\u2013NH bond.",
            "cite_spans": [
                {
                    "start": 729,
                    "end": 731,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 931,
                    "end": 933,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 935,
                    "end": 937,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 573,
                    "end": 574,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                },
                {
                    "start": 1171,
                    "end": 1172,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "Also, all 1H NMR spectra of nucleotide analogs 8a\u20138f and 8h showed almost identical patterns for a P\u2013CH(OH)\u2013CH2\u2013CH2\u2013NHC(O)\u2013CH2 chain and we reasoned that in methanol they adopt the same conformation 20 (Fig. 5) which resembles 18 in terms of antiperiplanar location of the phosphoryl and H2C3 groups. From 1H, 1H{31P}, and 13C NMR spectra of 8c, the following diagnostic coupling constants were extracted: 3J(H1\u2013H2a) = 3.1 Hz, 3J(H1\u2013H2b) = 10.7 Hz [30], 3J(P\u2013H2a) = 6.7 Hz, 3J(P\u2013H2b) = 9.5 Hz [31, 32], and 3J(P\u2013C3) = 16.1 Hz [33, 34] which fully confirm our conclusion.",
            "cite_spans": [
                {
                    "start": 449,
                    "end": 451,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 494,
                    "end": 496,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 498,
                    "end": 500,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 527,
                    "end": 529,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 531,
                    "end": 533,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                }
            ],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 208,
                    "end": 209,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "Thus, again the steric requirements of the diethoxyphosphoryl group and a H2C3\u2013NHC(O) substituent are responsible for stability of the antiperiplanar conformation 20. However, although all vicinal proton\u2013proton couplings were successfully calculated for a HaHbC2\u2013C3HaHb subunit in 8c, their values can only be interpreted in favor of a free rotation around a C2\u2013C3 bond and thus preclude any intramolecular H-bonding for amide moieties in 8a\u20138h.",
            "cite_spans": [],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "Similar to 1H NMR spectra of nucleotide analogs 7a\u20137h and 8a\u20138f and 8h, the spectra of the analogs 9a\u20139f and 9h in methanol displayed very similar patterns for a P\u2013CH2\u2013CH(OH)\u2013CH2\u2013NHC(O)\u2013CH2 portion. The values of 3J(P\u2013C3) = 15.4 Hz [33, 34] together with 3J(H1a\u2013H2) = 4.6 Hz and 3J(H1b\u2013H2) = 8.2 Hz [31, 32] found in 13C in 1H NMR spectra of 9a again suggest that the diethoxyphosphoryl and CH2\u2013NHC(O) groups for steric reasons prefer to exist in the anti conformation 21 (Fig. 5). This is commonly observed for \u03b2-hydroxyphosphonates [35]. This conclusion is further supported by the lack of the vicinal phosphorus\u2013HC2 coupling as expected for the gauche relationship within a H-C2\u2013C1-P unit [31, 32]. As in 8c, a free rotation within a CH2\u2013NHC(O) moiety in 9a is evident from the values of vicinal H2\u2013H3a/3b couplings.",
            "cite_spans": [
                {
                    "start": 233,
                    "end": 235,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 237,
                    "end": 239,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 300,
                    "end": 302,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 304,
                    "end": 306,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 535,
                    "end": 537,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 693,
                    "end": 695,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 697,
                    "end": 699,
                    "mention": "32",
                    "ref_id": "BIBREF25"
                }
            ],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 478,
                    "end": 479,
                    "mention": "5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "All phosphonates, i.e., 7a\u20137h, 8a\u20138f, 8h, 8j, 9a\u20139f, 9h, and 9j were evaluated for inhibitory activity against a wide variety of DNA and RNA viruses, using the following cell-based assays. The antiviral assays were performed in: (a) human embryonic lung (HEL) cells [herpes simplex virus-1 (KOS strain), herpes simplex virus-2 (G strain), thymidine kinase deficient (acyclovir resistant) herpes simplex virus-1 (TK\u2013 KOS ACVr strain), vaccinia virus, adenovirus-2, human coronavirus (229E), cytomegalovirus (AD-169 and Davis strains), varicella-zoster virus (TK+ VZV and TK\u2013 VZV strains)], (b) HeLa cell cultures (vesicular stomatitis virus, Coxsackie virus B4 and respiratory syncytial virus), (c) Vero cell cultures [para-influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, yellow fever virus], and (d) MDCK cell cultures [influenza A virus (H1N1 and H3N2 subtypes) and influenza B virus]. Ganciclovir, cidofovir, acyclovir, brivudin, zalcitabine, zanamivir, alovudine, amantadine, rimantadine, ribavirin, dextran sulfate (molecular weight 10,000, DS-10000), mycophenolic acid and Urtica dioica agglutinin (UDA) were used as the reference compounds. The antiviral activity was expressed as the EC50: the compound concentration required to reduce virus plaque formation (VZV) by 50% or to reduce virus-induced cytopathogenicity by 50% (other viruses). None of the tested compounds showed appreciable antiviral activity toward any of the tested DNA and RNA viruses at concentrations up to 100 \u03bcM, nor affected cell morphology of HEL, HeLa, Vero, and MDCL cells.",
            "cite_spans": [],
            "section": "Antiviral evaluation ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The 50% cytostatic inhibitory concentration (IC50) causing a 50% decrease in cell proliferation was determined for all phosphonates, i.e., 7a\u20137h, 8a\u20138f, 8h, 8j, 9a\u20139f, 9h, and 9j toward 9 cancerous cell lines [Capan-1 (pancreatic adenocarcinoma), Hap1 (chronic myeloid leukemia), HCT-116 (colorectal carcinoma), NCI-H460 (lung carcinoma), DND-41 (acute lymphoblastic leukemia), HL-60 (acute myeloid leukemia), K-562 (chronic myeloid leukemia), MM.1S (multiple myeloma), Z-138 non-Hodgkin lymphoma)] as well as normal retina (non cancerous) cells (hTERT RPE-1). Docetaxel and stauroporine were used as the reference compounds. Among all screened compounds, phosphonates 7c, 8c, and 9d were slightly cytostatic against multiple myeloma cells (MM.1S) with IC50 values 78.8, 91.3, and 40.7 \u03bcM, respectively, however, lower than reference drugs (IC50 values 3.6 and 16.6 for docetaxel and stauroporine, respectively). On the other hand, compound 9b showed noticeable inhibitory properties toward chronic myeloid leukemia (K-562) (IC50 = 28.8 \u03bcM), however, still lower than docetaxel (IC50 = 1.4 \u03bcM) and stauroporine (IC50 = 8.0 \u03bcM). All tested compounds were not toxic for normal, non-cancerous retina cells (hTERT RPE-1) at concentrations up to 100 \u03bcM.",
            "cite_spans": [],
            "section": "Cytostatic evaluation ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "In further studies on a concept of the replacement of the P\u2013CH2\u2013O\u2013CHR\u2013 fragment in acyclic nucleoside analogs (e.g., adefovir) for P\u2013X\u2013HN\u2013C(O)\u2013 moieties in addition to previously obtained series (X=CH2, CH2CH2, CH2CH2CH2, CH2OCH2CH2), nucleotide analogs containing hydroxyalkyl linkers (X=CH(OH)CH2, CH(OH)CH2CH2, CH2CH(OH)CH2) were synthesized. The coupling of the respective \u03c9-aminophosphonates and nucleobase-derived acetic acids was accomplished in good yields by application of EDC. Phosphonate\u2013nucleobase linkers in the synthesized analogs contain two fragments of restricted rotation, namely the amide bonds and P\u2013CH(OH)\u2013CH2\u2013N (compounds 7a\u20137h), P\u2013CH(OH)\u2013CH2\u2013C (compounds 8a\u20138h), and P\u2013CH2\u2013CH(OH)\u2013C (compounds 9a\u20139h) residues in which, as judged from 1H and 13C NMR spectral data, antiperiplanar disposition of P and N/C atoms results both from the steric bulkiness of O,O-diethyl phosphoryl group and intramolecular H-bonding. The phosphonates 7a\u20137h, 8a\u20138f, 8h, 8j, 9a\u20139f, 9h, and 9j were subjected to antiviral assays on a wide variety of DNA and RNA viruses but appeared inactive at concentrations up to 100 \u03bcM. Their cytostatic properties were evaluated on 9 cancerous cell lines and phosphonates 9b and 9d showed moderate activity towards myeloid leukemia (K-562) (IC50 = 28.8 \u03bcM) and multiple myeloma cells (MM.1S) (IC50 = 40.7 \u03bcM), respectively.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Studies on the analogous phosphonates containing functionalized amino groups within linkers are currently under way in this laboratory.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "A mixture of 3.60 g of the epoxide 14 (19.9 mmol) and 3.99 cm3 dibenzylamine (20.8 mmol) was heated at 60 \u00b0C for 20 h. After cooling, the crude product was purified on a silica gel column with a chloroform to give pure diethyl 2-(N,N-dibenzylamino)-1-hydroxyethanephosphonate (6.77 g) in 68% yield. In the next step a solution of 1.53 g of the diethyl 2-(N,N-dibenzylamino)-1-hydroxyethanephosphonate (4.05 mmol) in 10 cm3 ethanol was hydrogenated over 80 mg Pd\u2013C (10%) at room temperature for 72 h. The catalyst was removed on a layer of Celite; the solution was concentrated in vacuo to afford pure phosphonate 10 (0.860 g, 100%) as a yellowish oil.",
            "cite_spans": [],
            "section": "Diethyl 2-amino-1-hydroxyethanephosphonate 10 [16CR16bibr] ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "A mixture of 2.02 g of the protected aldehyde 16 (9.76 mmol), 1.13 cm3 diethyl phosphite (8.78 mmol), and 0.136 cm3 triethylamine (0.976 mmol) was stirred at room temperature for 24 h. After the solution was concentrated in vacuo, the residue was chromatographed on a silica gel column with a chloroform\u2013methanol mixture (200:1, 100:1 v/v) to give the phosphonate 17 (2.27 g, 67%) as a white powder. In the next step, a solution of 0.750 g of the phosphonate 17 (2.17 mmol) in 6 cm3 ethanol was hydrogenated over 30 mg Pd\u2013C (10%) at room temperature for 72 h. The suspension was filtered through a pad of Celite and washed with ethanol. The solution was concentrated in vacuo to afford pure 3-amino-1-hydroxypropanephosphonate 11 (0.460 g, 100%) as a yellowish oil.",
            "cite_spans": [],
            "section": "Diethyl 3-amino-1-hydroxypropanephosphonate 11 [19CR19bibr] ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.156 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.791 mmol) and 0.135 g (uracil-1-yl)acetic acid (13a, 0.791 mmol), the amide 7a (0.128 g, 46% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from methanol. M.p.: 174\u2013176 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3340, 3229, 2997, 2940, 2824, 1687, 1046, 1015 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.55 (d, J = 7.9 Hz, 1H, HC = CH), 5.72 (d, J = 7.9 Hz, 1H, HC = CH), 4.50 and 4.48 (AB, J = 16.7 Hz, 2H, C(O)CHaHb), 4.31\u20134.13 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (ddd, JH1\u2013H2b = 9.2 Hz, JH1-P = 8.1 Hz, JH1\u2013H2a = 3.7 Hz, 1H, PCHCH2), 3.73 (ddd, JH2a\u2013H2b = 13.9 Hz, JH2a-P = 7.2 Hz, JH2a\u2013H1 = 3.7 Hz, 1H, PCCHaHb), 3.39 (ddd ~ dt, JH2a\u2013H2b = 13.9 Hz, JH2b\u2013H1 = 9.2 Hz, JH2b-P = 8.5 Hz, 1H, PCCHaHb), 1.39 and 1.38 (2 \u00d7 t, J = 7.0 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.26, 165.33, 151.55, 146.38, 100.97, 65.88 (d, J = 164.4 Hz, PC), 63.05 and 62.75 (2 \u00d7 d, J = 7.3 Hz, 2 \u00d7 POC), 49.72, 41.12 (d, J = 8.6 Hz, PCC), 15.40 and 15.38 (2 \u00d7 d, J = 5.1 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.73 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxyethylphosphonate (7a, C12H20N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.050 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.240 mmol) and 0.040 g (uracil-1-yl)acetic acid (13a, 0.240 mmol), the amide 8a (0.040 g, 47% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from methanol\u2013diethyl ether. M.p.: 190\u2013191 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3333, 3231, 2995, 1698, 1673, 1244, 1028 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.56 (d, J = 8.0 Hz, 1H, HC = CH), 5.70 (d, J = 8.0 Hz, 1H, HC = CH), 4.45 (s, 2H, C(O)CH2), 4.29\u20134.12 (m, 4H, 2 \u00d7 POCH2CH3), 3.98 (ddd, J = 10.6 Hz, J = 7.3 Hz, J = 3.4 Hz, 1H, PCH), 3.51\u20133.41 (m, 2H, PCCCH2), 2.11\u20131.73 (m, 2H, PCCH2), 1.38 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 172.13, 169.35, 155.41, 151.31, 104.81, 68.25 (d, J = 167.3 Hz, PC), 66.83 and 66.49 (2 \u00d7 d, J = 7.7 Hz, 2 \u00d7 POC), 53.90, 39.61 (d, J = 16.4 Hz, PCCC), 34.73 (d, J = 3.4 Hz, PCC), 19.36 and 19.32 (2 \u00d7 d, J = 5.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 26.03 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxypropylphosphonate (8a, C13H22N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.139 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.658 mmol) and 0.112 g (uracil-1-yl)acetic acid (13a, 0.658 mmol) according to the general procedure was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallized from a methanol\u2013diethyl ether mixture to give compound 19a (0.112 g, 47% yield) as a white powder. M.p.: 124\u2013125 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3313, 3095, 3045, 2982, 2929, 1691, 1650, 1239, 1053, 1023 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.53 (d, J = 7.9 Hz, 1H, HC = CH), 5.69 (d, J = 7.9 Hz, 1H, HC = CH), 4.68 and 4.45 (AB, J = 16.6 Hz, 2H, C(O)CHaHb), 4.19\u20134.11 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (ddt, J = 8.2 Hz, J = 6.6 Hz, J = 4.8 Hz, J = 4.6 Hz, 1H, PCCH), 3.42 (dd, J = 13.6 Hz, J = 4.8 Hz, 1H, PCCCHaHb), 3.29 (ddd, J = 13.6 Hz, J = 6.6 Hz, J = 0.6 Hz, 1H, PCCCHaHb), 2.07 (ddd, J = 18.9 Hz, J = 15.5 Hz, J = 4.6 Hz, 1H, PCHaHb), 2.01 (ddd, J = 17.9 Hz, J = 15.5 Hz, J = 8.2 Hz, 1H, PCHaHb), 1.36 and 1.35 (2 \u00d7 t, J = 7.1 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.32, 165.40, 151.51, 146.46, 100.88, 65.14 (d, J = 3.9 Hz, PCC), 62.06 and 61.84 (2 \u00d7 d, J = 6.5 Hz, 2 \u00d7 POC), 49.92, 45.83 (d, J = 15.4 Hz, PCCC), 30.56 (d, J = 140.7 Hz, PC), 15.26 (d, J = 6.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.97 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-2-hydroxypropylphosphonate (9a, C13H22N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.107 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.543 mmol) and 0.102 g (5-fluorouracil-1-yl)acetic acid (13b, 0.543 mmol), the amide 7b (0.81 g, 41% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v). M.p.: 181\u2013183 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3381, 3196, 3049, 2995, 2829, 1736, 1700, 1661, 1217, 1025, 749 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.82 (d, J = 6.2 Hz, 1H, HC = CF), 4.47 and 4.44 (AB, J = 16.6 Hz, 2H, C(O)CHaHb), 4.31\u20134.15 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (ddd, J = 9.2 Hz, J = 8.2 Hz, J = 3.7 Hz, 1H, PCHCH2), 3.73 (ddd, J = 14.0 Hz, J = 6.9 Hz, J = 3.7 Hz, 1H, PCCHaHb), 3.45\u20133.33 (m, 1H, PCCHaHb), 1.39 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.10, 158.51 (d, J = 25.6 Hz), 150.26, 140.23 (d, J = 232.3 Hz), 130.31 (d, J = 34.0 Hz), 65.84 (d, J = 164.8 Hz, PC), 63.05 and 62.76 (2 \u00d7 d, J = 6.9 Hz, 2 \u00d7 POC), 49.70, 41.11 (d, J = 8.6 Hz, PCC), 15.40 and 15.37 (2 \u00d7 d, J = 5.0 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.71 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxyethylphosphonate (7b, C12H19FN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.160 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.758 mmol) and 0.143 g (5-fluorouracil-1-yl)acetic acid (13b, 0.758 mmol), the amide 8b (0.125 g, 43% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from a methanol\u2013diethyl ether mixture. M.p.: 211\u2013212 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3336, 3217, 3061, 2929, 1721, 1698, 1659, 1245, 1019, 975 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.80 (d, J = 6.1 Hz, 1H, HC = CF), 4.42 and 4.38 (AB, J = 16.6 Hz, 2H, C(O)CHaHb), 4.23\u20134.16 (m, 4H, 2 \u00d7 POCH2CH3), 3.96 (ddd, J = 10.7 Hz, J = 7.4 Hz, J = 3.1 Hz 1H, PCHCH2), 3.53\u20133.40 (m, 2H, PCCCH2), 2.03\u20131.96 (m, 1H, PCCHaCHb), 1.90\u20131.82 (m, 1H, PCCHaCHb), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.02, 158.57 (d, J = 25.6 Hz), 150.20, 140.22 (d, J = 232.0 Hz), 130.37 (d, J = 34.0 Hz), 64.37 (d, J = 166.1 Hz, PC), 62.90 and 62.55 (2 \u00d7 d, J = 7.1 Hz, 2 \u00d7 POC), 49.95, 35.69 (d, J = 16.1 Hz, PCCC), 30.78 (d, J = 3.0 Hz, PCC), 15.42 and 15.39 (2 \u00d7 d, J = 5.3 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 25.14 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxypropylphosphonate (8b, C13H21FN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.128 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.606 mmol) and 0.144 g (5-fluorouracil-1-yl)acetic acid (13b, 0.606 mmol), the amide 9b (0.074 g, 32% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and HPLC (C18 column, 25:70 methanol:water). M.p.: 126\u2013128 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{V} $$\\end{document}V\u00af = 3358, 3167, 3057, 2995, 2931, 2819, 1706, 1661, 1220, 1027, 858 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.80 (d, J = 6.2 Hz, 1H, HC = CF), 4.44 and 4.42 (AB, J = 16.8 Hz, 2H, C(O)CHaHb), 4.18\u20134.11 (m, 4H, 2 \u00d7 POCH2CH3), 4.10\u20134.05 (m, 1H, PCCH), 3.43 (dd, J = 13.6 Hz, J = 4.7 Hz, 1H, PCCCHaHb), 3.28 (ddd, J = 13.6 Hz, J = 6.5 Hz, J = 0.5 Hz, 1H, PCCCHaHb), 2.08 (ddd, J = 19.0 Hz, J = 15.5 Hz, J = 4.7 Hz, 1H, PCHaHb), 2.01 (ddd, J = 17.8 Hz, J = 15.5 Hz, J = 8.2 Hz, 1H, PCHaHb), 1.36 and 1.35 (2 \u00d7 t, J = 7.1 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.17, 158.67 (d, J = 26.0 Hz), 150.33, 140.23 (d, J = 232.2 Hz), 130.35 (d, J = 34.0 Hz), 65.13 (d, J = 3.5 Hz, PCC), 62.07 and 61.84 (2 \u00d7 d, J = 6.5 Hz, 2 \u00d7 POC), 49.91, 45.83 (d, J = 15.3 Hz, PCCC), 30.59 (d, J = 140.9 Hz, PC), 15.26 (d, J = 6.0 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.95 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-2-hydroxypropylphosphonate (9b, C13H21FN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.177 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.898 mmol) and 0.224 g (5-bromouracil-1-yl)acetic acid (13c, 0.898 mmol), the amide 7c (0.169 g, 44% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from a methanol\u2013diethyl ether mixture. M.p.: 183\u2013185 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3317, 3234, 3042, 2997, 2833, 1692, 1626, 1225, 1021, 622 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.00 (s, 1H, HC = CBr), 4.50 and 4.47 (AB, J = 16.4 Hz, 2H, C(O)CHaHb), 4.24\u20134.18 (m, 4H, 2 \u00d7 POCH2CH3), 4.07 (dt, J = 8.8 Hz, J = 3.7 Hz, 1H, PCHCH2), 3.71 (ddd, J = 13.9 Hz, J = 7.4 Hz, J = 3.7 Hz, 1H, PCCHaHb), 3.38 (dt, J = 13.9 Hz, J = 8.8 Hz, 1H, PCCHaHb), 1.37 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.03, 160.71, 150.96, 145.81, 95.18, 65.83 (d, J = 164.8 Hz, PC), 63.04 and 62.76 (2 \u00d7 d, J = 7.1 Hz, 2 \u00d7 POC), 49.73, 41.12 (d, J = 8.6 Hz, PCC), 15.40 and 15.38 (2 \u00d7 d, J = 5.1 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.71 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxyethylphosphonate (7c, C12H19BrN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.160 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.758 mmol) and 0.160 g (5-bromouracil-1-yl)acetic acid (13c, 0.758 mmol), the amide 8c (0.127 g, 44% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v). M.p.: 203\u2013205 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{V} $$\\end{document}V\u00af = 3326, 3189, 3059, 2997, 1725, 1674, 1247, 1021, 586 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.01 (s, 1H, HC = CBr), 4.45 (s, 2H, C(O)CH2), 4.23\u20134.16 (m, 4H, 2 \u00d7 POCH2CH3,), 3.96 (ddd, JH1\u2013H2b = 10.7 Hz, JH1-P = 7.4 Hz, JH1\u2013H2a = 3.1 Hz, 1H, PCH) 3.48 (ddd, JH3a\u2013H3b = 13.5 Hz, JH3a\u2013H2a = 8.2 Hz, JH2a-P = 7.0 Hz, 1H, PCCCHaHb), 3.41 (ddd, JH3a\u2013H3b = 13.5 Hz, JH3b\u2013H2a = 7.3 Hz, JH3b\u2013H2b = 4.9 Hz, 1H, PCCCHaHb), 1.99 (ddddd, JH2a\u2013H2b = 14.0 Hz, JH2a\u2013H3a = 8.2 Hz, JH2a\u2013H3b = 7.3 Hz, JH2a-P = 6.7 Hz, JH2a\u2013H1 = 3.1 Hz, 1H, PCCHaHb), 1.86 (ddddd, JH2a\u2013H2b = 14.0 Hz, JH2b\u2013H1 = 10.7 Hz, JH2b-P = 9.5 Hz, JH2b\u2013H3a = 7.0 Hz, JH2b\u2013H3b = 4.9 Hz, 1H, PCCHaHb) 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.95, 160.77, 150.89, 145.86, 95.13, 64.35 (d, J = 167.4 Hz, PC), 62.90 and 62.56 (2 \u00d7 d, J = 7.1 Hz, 2 \u00d7 POC), 49.99, 35.68 (d, J = 16.1 Hz, PCCC), 30.78 (d, J = 3.0 Hz, PCC), 15.42 and 15.38 (2 \u00d7 d, J = 4.8 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 25.15 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxypropylphosphonate (8c, C13H21BrN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.545 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 2.58 mmol) and 0.642 g (5-bromouracil-1-yl)acetic acid (13c, 2.58 mmol), the amide 9c (0.552 g, 48% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and HPLC (C18 column, 25:70 methanol:water). M.p.: 108\u2013109 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3488, 3350, 3159, 3034, 2993, 2928, 2838, 1714, 1668, 1240, 1021, 632 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 7.73 (brs, 2H, HC = CBr, NH), 4.47 (s, 2H, C(O)CH2), 4.22\u20134.11 (m, 5H, 2 \u00d7 POCH2CH3, PCCH), 3.56\u20133.53 (m, 1H, PCCCHaHb), 3.30 (dt, J = 13.1 Hz, J = 6.4 Hz, 1H, PCCCHaHb), 2.09\u20131.97 (m, 2H, PCH2), 1.35 and 1.34 (2 \u00d7 t, J = 7.0 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 167.20, 160.14, 151.06, 144.87, 96.72, 65.73 (d, J = 3.1 Hz, PCC), 62.33 and 62.27 (2 \u00d7 d, J = 6.6 Hz, 2 \u00d7 POC), 50.67, 46.13 (d, J = 17.3 Hz, PCCC), 30.93 (d, J = 140.4 Hz, PC), 16.39 and 16.36 (2 \u00d7 d, J = 6.1 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 29.23 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-2-hydroxypropylphosphonate (9c, C13H21BrN3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.158 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.801 mmol) and 0.148 g (thymine-1-yl)acetic acid (13d, 0.801 mmol), the amide 7d (0.145 g, 50% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from a methanol\u2013ethyl acetate mixture. M.p.: 186\u2013187 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3318, 3261, 3043, 2943, 2910, 2830, 1697, 1653, 1245, 1018 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.39 (q, J = 1.1 Hz, 1H, HC = CCH3), 4.47 and 4.44 (AB, J = 16.6 Hz, 2H, C(O)CHaHb), 4.31\u20134.14 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (ddd, JH1\u2013H2b = 9.2 Hz, JH1-P = 8.2 Hz, JH1\u2013H2a = 3.6 Hz, 1H, PCHCH2), 3.73 (ddd, JH2a\u2013H2b = 14.0 Hz, JH2a-P = 7.2 Hz, JH2a\u2013H1 = 3.6 Hz, 1H, PCCHaHb), 3.38 (ddd ~ dt, JH2b\u2013H2a = 14.0 Hz, JH2b\u2013H1 = 9.2 Hz, JH2b-P = 8.5 Hz, 1H, PCCHaHb), 1.92 (d, J = 1.1 Hz, 3H, HC = CCH3), 1.39 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.45, 165.54, 151.72, 142.17, 109.78, 65.84 (d, J = 164.3 Hz, PC), 63.04 and 62.73 (2 \u00d7 d, J = 6.9 Hz, 2 \u00d7 POC), 49.56, 41.11 (d, J = 8.6 Hz, PCC), 15.40 and 15.36 (2 \u00d7 d, J = 5.1 Hz, 2 \u00d7 POCC), 10.78 ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.74 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxyethylphosphonate (7d, C13H22N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.180 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.852 mmol) and 0.157 g (thymine-1-yl)acetic acid (13d, 0.852 mmol), the amide 8d (0.166 g, 52% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from a methanol\u2013diethyl ether mixture. M.p.: 183\u2013184 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{V} $$\\end{document}V\u00af = 3333, 3238, 2987, 2833, 1665, 1236, 1024 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.38 (brq, J = 0.8 Hz, 1H, HC = CCH3), 4.41 and 4.39 (AB, J = 16.6 Hz, 2H, C(O)CHaHb), 4.22\u20134.16 (m, 4H, 2 \u00d7 POCH2CH3), 3.96 (ddd, J = 10.6 Hz, J = 7.4 Hz, J = 3.1 Hz, 1H, PCHCH2), 3.49\u20133.39 (m, 2H, PCCCHaHb), 2.02\u20131.95 (m, 1H, PCCHaHb), 1.90\u20131.81 (m, 1H, PCCHaHb), 1.90 (d, J = 0.8 Hz, 3H, HC = CCH3), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.37, 165.60, 151.64, 142.23, 109.68, 64.38 (d, J = 167.3 Hz, PC), 62.88 and 62.54 (2 \u00d7 d, J = 7.2 Hz, 2 \u00d7 POC), 49.79, 35.66 (d, J = 15.9 Hz, PCCC), 30.78 (d, J = 2.7 Hz, PCC),15.41 and 15.36 (2 \u00d7 d, J = 4.8 Hz, 2 \u00d7 POCC), 10.78 ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 25.14 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-1-hydroxypropylphosphonate (8d, C14H24N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.127 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.601 mmol) and 0.111 g (thymine-1-yl)acetic acid (13d, 0.601 mmol), the amide 9d (0.113 g, 47% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from a methanol\u2013ethyl acetate mixture. M.p.: 157\u2013158 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3428, 3186, 3057, 2991, 2936, 2828, 1697, 1651, 1225, 1030 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.38 (q, J = 1.0 Hz, 1H, HC = CCH3), 4.43 (s, 2H, C(O)CH2), 4.17\u20134.13 (m, 4H, 2 \u00d7 POCH2CH3), 4.12\u20134.08 (m, 1H, PCCH), 3.42 (dd, J = 13.6 Hz, J = 4.7 Hz, 1H, PCCCHaHb), 3.28 (dd, J = 13.6 Hz, J = 6.7 Hz, 1H, PCCCHaHb), 2.08 (ddd, J = 18.9 Hz, J = 15.5 Hz, J = 4.7 Hz, 1H, PCHaHb), 2.01 (ddd, J = 17.8 Hz, J = 15.5 Hz, J = 7.4 Hz, 1H, PCHaHb), 1.90 (d, J = 1.0 Hz, 3H, HC = CCH3), 1.36 and 1.35 (2 \u00d7 t, J = 7.1 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm;13C NMR (151 MHz, CD3OD): \u03b4 = 168.51, 165.57, 151.68, 142.26, 109.67, 65.13 (d, J = 3.6 Hz, PCC), 62.06 and 61.83 (2 \u00d7 d, J = 6.4 Hz, 2 \u00d7 POC), 49.76, 45.83 (d, J = 15.4 Hz, PCCC), 30.57 (d, J = 140.7 Hz, PC), 15.26 (d, J = 6.3 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.97 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]-2-hydroxypropylphosphonate (9d, C14H24N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.090 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.456 mmol) and 0.138 g [N4-(benzyloxycarbonyl)cytosine-1-yl]acetic acid (13e, 0.456 mmol), the amide 7e (0.074 g, 34% yield) was obtained as a colorless oil after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v). IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3279, 3088, 2984, 2931, 1749, 1661, 1215, 1023 cm\u22121; 1H NMR (200 MHz, CDCl3): \u03b4 = 10.39 (brs, 1H, NH), 8.75 (brt, 1H, NH), 7.72 (d, J = 7.4 Hz, 1H, HC = CCH), 7.38\u20137.28 (m, 6H, C6H5, HC = CCH), 5.85 (brs, 1H, NH), 5.21 (s, 2H, CH2C6H5), 4.59 and 4.48 (AB, J = 14.9 Hz, 2H, C(O)CHaHb), 4.20\u20133.82 (m, 6H, 2 \u00d7 POCH2CH3, PCHCHaHb), 3.58\u20133.38 (m, 1H, PCCHaHb), 1.31 and 1.20 (2 \u00d7 t, J = 7.0 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm;13C NMR (151 MHz, CDCl3): \u03b4 = 166.81, 163.67, 156.06, 153.04, 149.30, 135.44, 128.53, 128.37, 128.01, 95.99, 67.54, 66.89 (d, J = 161.6 Hz, PC), 63.47 and 62.55 (2 \u00d7 d, J = 6.8 Hz, 2 \u00d7 POC), 52.45, 40.79 (d, J = 10.1 Hz, PCC), 16.41 (2 \u00d7 d, J = 5.4 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CDCl3): \u03b4 = 24.42 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[4-[(benzyloxycarbonyl)amino]-2-oxopyrimidin-1(2H)-yl]acetamido]-1-hydroxyethylphosphonate (7e, C20H27N4O8P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.166 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.787 mmol) and 0.239 g [N4-(benzyloxycarbonyl)cytosine-1-yl]acetic acid (13e, 0.787 mmol), the amide 8e (0.248 g, 64% yield) was obtained as a white solid after crystallization from a methanol\u2013diethyl ether mixture. M.p.: 164\u2013165 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{V} $$\\end{document}V\u00af = 3291, 3093, 2977, 1753, 1689, 1657, 1226, 1027 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.93 (d, J = 7.3 Hz, 1H, HC = CCH), 7.45\u20137.31 (m, 6H, C6H5, HC = CCH), 5.25 (s, 2H, CH2C6H5), 4.59 and 4.54 (AB, J = 15.7 Hz, 2H, C(O)CHaHb), 4.22\u20134.15 (m, 4H, 2 \u00d7 POCH2CH3), 3.97 (ddd, J = 10.7 Hz, J = 7.4 Hz, J = 3.1 Hz, 1H, PCHCH2), 3.50\u20133.40 (m, 2H, PCCCH2), 2.09\u20131.96 (m, 1H, PCCHaHb), 1.92\u20131.82 (m, 1H, PCCHaHb), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.91, 164.05, 150.18, 135.81, 128.20, 128.20, 128.04, 127.89, 127.89, 95.35, 67.20, 64.35 (d, J = 167.4 Hz, PC), 62.88 and 61.54 (2 \u00d7 d, J = 7.3 Hz, 2 \u00d7 POC), 52.01, 35.71 (d, J = 16.2 Hz, PCCC), 30.75 (d, J = 2.7 Hz, PCC), 15.42 and 15.38 (2 \u00d7 d, J = 4.8 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 25.15 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[4-[(benzyloxycarbonyl)amino]-2-oxopyrimidin-1(2H)-yl]acetamido]-1-hydroxypropylphosphonate (8e, C21H29N4O8P\u2009\u00d7\u20090.5H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.119 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.563 mmol) and 0.171 g [N4-(benzyloxycarbonyl)cytosine-1-yl]acetic acid (13e, 0.563 mmol), the amide 9e (0.100 g, 36% yield) was obtained as a white solid after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from ethanol. M.p.: 123\u2013125 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3268, 3088, 2981, 2931, 1746, 1666, 1661, 1218, 1027 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.96 (d, J = 7.4 Hz, 1H, HC = CCH), 7.52\u20137.33 (m, 6H, C6H5, HC = CCH), 5.27 (s, 2H, CH2C6H5), 4.62 (s, 2H, C(O)CH2), 4.25\u20134.02 (m, 5H, 2 \u00d7 POCH2CH3, PCCH), 3.46 (dd, J = 13.9 Hz, J = 4.7 Hz, 1H, PCCCHaHb), 3.25 (dd, J = 13.9 Hz, J = 7.3 Hz, 1H, PCCCHaHb), 2.21\u20131.91 (m, 2H, PCH2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.05, 164.03, 157.12, 153.16, 150.26, 135.80, 128.21, 128.21, 128.05, 127.89, 127.89, 90.37, 67.21, 65.14 (d, J = 3.6 Hz, PCC), 62.05 and 61.83 (2 \u00d7 d, J = 6.4 Hz, 2 \u00d7 POC), 52.02, 45.93 (d, J = 15.4 Hz, PCCC), 30.58 (d, J = 140.7 Hz, PC), 15.29 (d, J = 6.0 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 30.88 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[4-[(benzyloxycarbonyl)amino]-2-oxopyrimidin-1(2H)-yl]acetamido]-2-hydroxypropylphosphonate (9e, C21H29N4O8P\u2009\u00d7\u20090.5H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.158 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.801 mmol) and 0.176 g (3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (13f, 0.801 mmol), the pure amide 7f (0.211 g, 66% yield) was obtained as a white powder after a mere filtration of the reaction mixture. M.p.: 225\u2013226 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3248, 3070, 2986, 2935, 1735, 1637, 1040 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.06 (dd, J = 7.9 Hz, J = 1.0 Hz, 1H, Haromat.), 7.69 (dt, J = 8.4 Hz, J = 1.0 Hz, 1H, Haromat.), 7.27 (dt, J = 7.9 Hz, J = 0.5 Hz, 1H, Haromat.), 7.22 (d, J = 8.4 Hz, 1H, Haromat.), 4.76 and 4.70 (AB, J = 16.0 Hz, 2H, C(O)CHaHb), 4.24\u20134.18 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (dt, J = 9.2 Hz, J = 3.7 Hz, 1H, PCHCH2), 3.73 (ddd, J = 13.9 Hz, J = 6.2 Hz, J = 3.7 Hz, 1H, PCCHaHb), 3.37\u20133.31 (m, 1H, PCCHaHb), 1.37 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 166.87, 162.78, 150.70, 139.59, 135.06, 127.52, 122.75, 114.90, 114.02, 65.90 (d, J = 164.6 Hz, PC), 63.00 and 62.73 (2 \u00d7 d, J = 6.6 Hz, 2 \u00d7 POC), 42.44, 41.16 (d, J = 8.8 Hz, PCC), 15.38 and 15.37 (2 \u00d7 d, J = 5.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.05 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]-1-hydroxyethylphosphonate (7f, C16H22N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.180 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.852 mmol) and 0.187 g (3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (13f, 0.852 mmol), the amide 8f (0.168 g, 48% yield) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and crystallization from an ethanol\u2013diethyl ether mixture. M.p.: 205\u2013208 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3256, 3205, 3075, 2984, 2954, 1736, 1654, 1635, 1024 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.01(d, J = 7.8 Hz, 1H, Haromat.), 7.69 (dt, J = 8.4 Hz, J = 1.2 Hz, 1H, Haromat.), 7.27 (t, J = 7.8 Hz, 1H, Haromat.), 7.22 (d, J = 8.3 Hz, 1H, Haromat.), 4.71 and 4.68 (AB, J = 16.0 Hz, 2H, C(O)CHaHb), 4.23\u20134.16 (m, 4H, 2 \u00d7 POCH2CH3), 3.99 (ddd, J = 10.7 Hz, J = 7.7 Hz, J = 3.0 Hz, 1H, PCHCH2), 3.52\u20133.47 (m, 1H, PCCCHaHb), 3.41\u20133.37 (m, 1H, PCCCHaHb), 2.03\u20131.96 (m, 1H, PCCHaHb), 1.89\u20131.81 (m, 1H, PCCHaHb), 1.35 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.91, 162.84, 150.86, 139.61, 135.03, 127.51, 122.51, 114.88, 114.06, 64.21 (d, J = 167.3 Hz, PC), 62.86 and 62.53 (2 \u00d7 d, J = 7.1 Hz, 2 \u00d7 POC), 42.56, 35.49 (d, J = 16.0 Hz, PCCC), 30.84 (d, J = 3.0 Hz, PCC), 15.41 and 15.38 (2 \u00d7 d, J = 5.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 25.29 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]-1-hydroxypropylphosphonate (8f, C17H24N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.127 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.601 mmol) and 0.132 g (3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (13f, 0.601 mmol), the amide 9f (0.131 g, 53% yield) was obtained as a white solid after crystallization from an ethanol\u2013diethyl ether mixture. M.p.: 168\u2013169 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\bar{V} $$\\end{document}V\u00af = 3378, 3249, 3201, 2985, 2946, 1734, 1656, 1638, 1020 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.08 (ddd, J = 8.0 Hz, J = 1.0 Hz, J = 0.5 Hz, 1H, Haromat.), 7.71 (ddd, J = 8.2 Hz, J = 7.3 Hz, J = 1.5 Hz, 1H, Haromat.), 7.32\u20137.20 (m, 2H, Haromat.), 4.74 (s, 2H, C(O)CH2), 4.24\u20134.03 (m, 5H, 2 \u00d7 POCH2CH3, PCCH), 3.44 (dd, J = 13.5 Hz, J = 5.1 Hz, 1H, PCCCHaHb), 3.31 (ddd, J = 13.5 Hz, J = 6.5 Hz, J = 1.6 Hz, 1H, PCCCHaHb), 2.13 (ddd, J = 18.8 Hz, J = 15.5 Hz, J = 4.6 Hz, 1H, PCHaHb), 1.99 (ddd, J = 17.7 Hz, J = 15.5 Hz, J = 8.2 Hz, 1H, PCHaHb), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.98, 162.83, 150.87, 139.60, 135.04, 127.51, 122.71, 114.89, 114.05, 65.24 (d, J = 4.2 Hz, PCC), 62.04 and 61.83 (2 \u00d7 d, J = 6.2 Hz, 2 \u00d7 POC), 45.82 (d, J = 15.6 Hz, PCCC), 42.55, 30.44 (d, J = 140.7 Hz, PC), 15.27 (d, J = 6.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 31.11 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]-2-hydroxypropylphosphonate (9f, C17H24N3O7P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.097 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 0.492 mmol) and 0.290 g [6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (13g, 0.492 mmol), the amide 7g (0.142 g, 50% yield) was obtained as a colorless oil after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v). IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3297, 3090, 2982, 2934, 2873, 1788, 1756, 1693, 1250, 1024 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 8.87 (s, 1H), 8.29 (s, 1H), 7.32 (t, J = 5.3 Hz, 1H, NH), 5.02 and 4.99 (AB, J = 16.3 Hz, 2H, C(O)CHaHb), 4.60 (t, J = 6.6 Hz, 1H, OH), 4.21\u20134.17 (m, 4H, 2 \u00d7 POCH2CH3), 4.10\u20134.05 (m, 1H, PCHCH2), 3.91 (ddt, J = 14.1 Hz, J = 6.6 Hz, J = 3.7 Hz, 1H, PCCHaHb), 3.44\u20133.33 (m, 1H, PCCHaHb), 1.48 (s, 18 H, 6 \u00d7 CH3), 1.36 and 1.35 (2 \u00d7 t, J = 7.1 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 166.60, 153.52, 152.08, 150.46, 150.25, 146.08, 128.39, 83.95, 66.61 (d, J = 163.0 Hz, PC), 63.23 and 63.08 (2 \u00d7 d, J = 7.3 Hz, 2 \u00d7 POC), 49.98, 41.60 (d, J = 5.8 Hz, PCC), 27.79, 16.43 (d, J = 5.5 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CDCl3): \u03b4 = 21.90 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetamido]-1-hydroxyethylphosphonate (7g, C23H37N6O9P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.180 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 0.852 mmol) and 0.335 g [6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (13g, 0.852 mmol), the crude product 8g contaminated with triethylamine hydrochloride (0.246 g, 49%) was obtained as a yellowish oil after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1 v/v). Further purification with HPLC (water\u2013methanol) gave pure 8j (0.030 g, 7%) and a 7:3 mixture of 8j and 8g (0.125 g). Yellowish oil; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3289, 3091, 2982, 2935, 1787, 1748, 1247, 1026 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 8.70 (s, 1H), 8.21 (brs, 1H), 8.12 (s, 1H), 7.64 (brt, J = 5.4 Hz, 1H), 4.95 (s, 2H, C(O)CH2), 4.61 (brs, 1H, OH), 4.21\u20134.12 (m, 4H, 2 \u00d7 POCH2CH3), 4.03\u20133.98 (m, 1H), 3.65\u20133.60 (m, 1H), 3.46\u20133.41 (m, 1H), 2.09\u20131.95 (m, 1H), 1.93\u20131.84 (m, 1H), 1.58 (s, 9H, 3 \u00d7 CH3), 1.33 and 1.32 (2 \u00d7 t, J = 7.0 Hz, 2 \u00d7 3H, 2 \u00d7 POCH2CH3) ppm;13C NMR (151 MHz, CDCl3): \u03b4 = 166.19, 153.41, 152.19, 150.57, 150.46, 145.55, 128.57, 84.00, 65.99 (d, J = 165.2 Hz, PC), 62.93 and 62.89 (2 \u00d7 d, J = 6.3 Hz, 2 \u00d7 POC), 46.40, 36.84 (d, J = 15.1 Hz, PCCC), 30.66 (PCC), 27.82, 16.49 (d, J = 5.5 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CDCl3): \u03b4 = 24.32 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[6-(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetamido]-1-hydroxypropylphosphonate (8j, C19H31N6O7P\u2009\u00d7\u20092H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.123 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 0.582 mmol) and 0.229 g [6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (13g, 0.582 mmol), the crude product 9g contaminated with triethylamine hydrochloride (0.197 g, 57%) was obtained as a colorless oil after purification on a silica gel column with chloroform\u2013methanol mixtures (100:1, 50:1 v/v). Further purification with HPLC (water\u2013methanol) gave pure 9j (0.019 g, 7%) and a 8:2 mixture of 9j and 9g (0.094 g). Colorless oil; IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3271, 30,881, 2992, 2955, 1782, 1760, 1234, 1023 cm\u22121; 1H NMR (200 MHz, CDCl3): \u03b4 = 8.70 (s, 1H), 8.12 (brs, 1H), 8.09 (s, 1H), 7.48 (brt, J = 6.2 Hz, 1H), 4.95 (s, 2H, C(O)CH2), 4.63 (brs, 1H, OH), 4.22\u20133.99 (m, 5H, 2 \u00d7 POCH2CH3, PCCH), 3.62\u20133.46 (m, 1H), 3.37\u20133.24 (m, 1H), 2.10\u20131.88 (m, 2H), 1.56 (s, 9H, 3 \u00d7 CH3), 1.30 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 166.39, 152.92, 151.16, 149.98, 149.75, 143.30, 121.37, 82.30, 65.59 (d, J = 4.3 Hz, PCC), 62.18 and 62.15 (2 \u00d7 d, J = 5.5 Hz, 2 \u00d7 POC), 46.28, 46.04 (d, J = 18.4 Hz, PCCC), 30.90 (d, J = 140.2 Hz, PC), 28.14, 16.37 and 16.33 (2 \u00d7 d, J = 4.6 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CDCl3): \u03b4 = 30.03 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[6-(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetamido]-2-hydroxypropylphosphonate (9j, C19H31N6O7P\u2009\u00d7\u2009H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0. 322 g diethyl 2-amino-1-hydroxyethylphosphonate (10, 1.63 mmol) and 0.372 g (2-amino-6-chloropurin-9-yl)acetic acid (13h, 1.63 mmol), the amide 7h (0.278 g, 27%) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1, 10:1 v/v). M.p.: 206\u2013208 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3457, 3347, 3212, 3044, 2991, 2930, 1672, 1632, 1565, 1249, 1027, 705 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.10 (s, 1H), 4.94\u20134.88 (m, 2H, C(O)CHaHb), 4.30\u20134.13 (m, 4H, 2 \u00d7 POCH2CH3), 4.08 (ddd, J = 9.1 Hz, J = 7.9 Hz, J = 3.7 Hz,1H, PCHCH2), 3.72 (ddd, J = 14.0 Hz, J = 7.3 Hz, J = 3.7 Hz, 1H, PCCHaHb), 3.48\u20133.37 (m, 1H, PCCHaHb), 1.38 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.55, 160.31, 154.17, 150.18, 143.87, 123.23, 65.80 (d, J = 164.6 Hz, PC), 63.05 and 62.75 (2 \u00d7 d, J = 7.3 Hz, 2 \u00d7 POC), 41.17, 41.13 (d, J = 8.5 Hz, PCC), 15.40 and 15.73 (2 \u00d7 d, J = 5.2 Hz, 2 \u00d7 POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.67 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]-1-hydroxyethylphosphonate (7h, C13H20ClN6O5P) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0. 366 g diethyl 3-amino-1-hydroxypropylphosphonate (11, 1.71 mmol) and 0.389 g (2-amino-6-chloropurin-9-yl)acetic acid (13h, 1.71 mmol), the amide 8h (0.099 g, 14%) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1, 10:1 v/v) and crystallization from methanol. M.p.: 183\u2013184 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3401, 3278, 3213, 3089, 2980, 2935, 2864, 1690, 1631, 1223, 1031, 971 cm\u22121; 1H NMR (600 MHz, DMSO-d6): \u03b4 = 8.05 (s, 1H), 6.90 (brs, 2H, NH2) 5.50 (t, J = 7.0 Hz, 1H, OH), 4.73 (s, 2H, C(O)CH2), 4.11\u20133.94 (m, 4H, 2 \u00d7 POCH2CH3), 3.87\u20133.71 (m, 1H, PCH), 3.45\u20133.25 (m, 2H, PCCCHaHb), 1.85\u20131.50 (m, 2H, PCCH2), 1.23 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm; 13C NMR (151 MHz, DMSO-d6): \u03b4 = 166.56, 160.28, 154.88, 149.69, 144.56, 123.57, 64.46 (d, J = 164.6 Hz, PC), 62.28 and 61.94 (2 \u00d7 d, J = 6.8 Hz, 2 \u00d7 POC), 45.505, 36.08 (d, J = 17.1 Hz, PCCC), 31.60 (d, J = 2.6 Hz, PCC), 16.86 and 16.83 (2 \u00d7 d, J = 5.0 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, DMSO-d6): \u03b4 = 24.74 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]-1-hydroxypropylphosphonate (8h, C14H22ClN6O5P\u2009\u00d7\u20090.75H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "According to the general procedure from 0.485 g diethyl 3-amino-2-hydroxypropylphosphonate (12, 2.30 mmol) and 0.523 g (2-amino-6-chloropurin-9-yl)acetic acid (13h, 2.30 mmol), the amide 9h (0.210 g, 22%) was obtained as a white powder after purification on a silica gel column with chloroform\u2013methanol mixtures (50:1, 20:1, 10:1 v/v) and crystallization from an ethanol\u2013diethyl ether mixture. M.p.: 163\u2013164 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overline{V} $$\\end{document}V\u00af = 3399, 3280, 3245, 3091, 2981, 2936, 2907, 1690, 1614, 1224, 1031, 868 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.07 (s, 1H), 4.92 and 4.88 (AB, J = 16.6 Hz, 2H, C(O)CH2), 4.18\u20134.06 (m, 5H, 2 \u00d7 POCH2CH3, PCCH), 3.42 (dd, J = 13.7 Hz, J = 4.8 Hz, 1H, PCCCHaHb), 3.31 (ddd, J = 13.7 Hz, J = 6.5 Hz, J = 1.0 Hz, 1H, PCCCHaHb), 2.11\u20131.98 (m, 2H, PCH2), 1.34 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH3) ppm;13C NMR (151 MHz, CD3OD): \u03b4 = 167.58, 160.31, 154.18, 150.20, 143.88, 123.28, 65.13 (d, J = 3.5 Hz, PCC), 62.08 and 61.83 (2 \u00d7 d, J = 6.6 Hz, 2 \u00d7 POC), 45.85 (d, J = 15.3 Hz, PCCC), 45.12, 30.62 (d, J = 140.9 Hz, PC), 15.25 (2 \u00d7 d, J = 5.9 Hz, 2 \u00d7 POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.94 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]-2-hydroxypropylphosphonate (9h, C14H22ClN6O5P\u2009\u00d7\u20090.25H2O) ::: General procedure ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The compounds were evaluated against different herpes viruses, including herpes simplex virus type 1 (HSV-1) strain KOS, thymidine kinase-deficient (TK\u2212) HSV-1 KOS strain resistant to ACV (ACVr), herpes simplex virus type 2 (HSV-2) strain G, varicella-zoster virus (VZV) strain Oka, TK\u2212 VZV strain 07-1, human cytomegalovirus (HCMV) strains AD-169 and Davis as well as vaccinia virus, adeno virus-2, human coronavirus, para-influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, respiratory syncytial virus (RSV) and influenza A virus subtypes H1N1 (A/PR/8), H3N2 (A/HK/7/87) and influenza B virus (B/HK/5/72), were based on inhibition of virus-induced cytopathicity or plaque formation in human embryonic lung (HEL) fibroblasts, African green monkey kidney cells (Vero), human epithelial cervix carcinoma cells (HeLa) or Madin Darby canine kidney cells (MDCK). Confluent cell cultures in microtiter 96-well plates were inoculated with 100 CCID50 of virus (1 CCID50 being the virus dose to infect 50% of the cell cultures) or with 20 plaque forming units (PFU) and the cell cultures were incubated in the presence of varying concentrations of the test compounds. Viral cytopathicity or plaque formation (VZV) was recorded as soon as it reached completion in the control virus-infected cell cultures that were not treated with the test compounds. Antiviral activity was expressed as the EC50 or compound concentration required reducing virus-induced cytopathicity or viral plaque formation by 50%. Cytotoxicity of the test compounds was expressed as the minimum cytotoxic concentration (MCC) or the compound concentration that caused a microscopically detectable alteration of cell morphology.",
            "cite_spans": [],
            "section": "Antiviral activity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "All assays were performed in 96-well microtiter plates. To each well were added (5\u20137.5) \u00d7 104 tumor cells and a given amount of the test compound. The cells were allowed to proliferate at 37 \u00b0C in a humidified CO2-controlled atmosphere. At the end of the incubation period, the cells were counted in a Coulter counter. The IC50 (50% inhibitory concentration) was defined as the concentration of the compound that inhibited cell proliferation by 50%.",
            "cite_spans": [],
            "section": "Cytostatic activity assays ::: Experimental",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Fig.\u00a01: Structures of adefovir (1), tenofovir (2), (S)-HMPA (3), and cidofovir (4)",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig.\u00a02: Structures of previously described and newly designed phosphonates as acyclic nucleoside phosphonates (B = canonical nucleobases; B\u2032 = nucleobase analogs: see Scheme 1)",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig.\u00a03: Guanine phosphonate analogs 7i, 8i, 9i and NH-Boc adenine phosphonates 8j and 9j",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Fig.\u00a04: Preferred conformations 18/19 of nucleotide analogs 7a\u20137h",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Fig.\u00a05: Preferred conformations 20 and 21 of nucleotide analogs 8a\u20138h and 9a\u20139h",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Biochem Pharmacol",
            "volume": "73",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bcp.2006.09.014"
                ]
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Hecker",
                    "suffix": ""
                },
                {
                    "first": "MD",
                    "middle": [],
                    "last": "Erion",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Med Chem",
            "volume": "51",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm701260b"
                ]
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Med Chem",
            "volume": "53",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm900932g"
                ]
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Pradere",
                    "suffix": ""
                },
                {
                    "first": "EC",
                    "middle": [],
                    "last": "Garnier-Amblard",
                    "suffix": ""
                },
                {
                    "first": "SJ",
                    "middle": [],
                    "last": "Coats",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Amblard",
                    "suffix": ""
                },
                {
                    "first": "RF",
                    "middle": [],
                    "last": "Schinazi",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Chem Rev",
            "volume": "114",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/cr5002035"
                ]
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [
                {
                    "first": "IE",
                    "middle": [],
                    "last": "G\u0142owacka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Graciela",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "DG",
                    "middle": [],
                    "last": "Piotrowska",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Bioorg Med Chem",
            "volume": "22",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2014.05.020"
                ]
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [
                {
                    "first": "IE",
                    "middle": [],
                    "last": "G\u0142owacka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Wr\u00f3blewski",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur J Med Chem",
            "volume": "70",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.ejmech.2013.10.057"
                ]
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [
                {
                    "first": "CE",
                    "middle": [],
                    "last": "Griffin",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Kundu",
                    "suffix": ""
                }
            ],
            "year": 1969,
            "venue": "J Org Chem",
            "volume": "34",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jo01258a002"
                ]
            }
        },
        "BIBREF7": {
            "title": "",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zygmunt",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mastalerz",
                    "suffix": ""
                }
            ],
            "year": 1978,
            "venue": "Pol J Chem",
            "volume": "52",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Wr\u00f3blewski",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ha\u0142ajewska-Wosik",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Tetrahedron",
            "volume": "11",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0957-4166(00)00171-3"
                ]
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Chin J Synth Chem",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med Res Rev",
            "volume": "33",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/med.21274"
                ]
            }
        },
        "BIBREF12": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "",
            "authors": [
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Wheeler",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Liddle",
                    "suffix": ""
                }
            ],
            "year": 1908,
            "venue": "J Am Chem Soc",
            "volume": "30",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja01949a014"
                ]
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tada",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Bull Chem Soc Jpn",
            "volume": "48",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1246/bcsj.48.3427"
                ]
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ferrer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shevchenko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Eritja",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Bioorg Med Chem",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0968-0896(99)00308-9"
                ]
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Rabinowitz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gurin",
                    "suffix": ""
                }
            ],
            "year": 1953,
            "venue": "J Am Chem Soc",
            "volume": "75",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja01118a525"
                ]
            }
        },
        "BIBREF17": {
            "title": "",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Tetrahedron",
            "volume": "68",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.tet.2012.08.028"
                ]
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [
                {
                    "first": "AR",
                    "middle": [],
                    "last": "Katritzky",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Narindoshvili",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Org Biomol Chem",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/b806141f"
                ]
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wojciechowski",
                    "suffix": ""
                },
                {
                    "first": "RHE",
                    "middle": [],
                    "last": "Hudson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Org Chem",
            "volume": "73",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jo800195j"
                ]
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hockova",
                    "suffix": ""
                },
                {
                    "first": "DT",
                    "middle": [],
                    "last": "Keough",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Janeba",
                    "suffix": ""
                },
                {
                    "first": "TH",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "de Jersey",
                    "suffix": ""
                },
                {
                    "first": "LW",
                    "middle": [],
                    "last": "Guddat",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Med Chem",
            "volume": "55",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm300662d"
                ]
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Schwergold",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Depecker",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Di Giorgio",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Patino",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jossinet",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ehresmann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Terreux",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cabrol-Bass",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Condom",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Tetrahedron",
            "volume": "58",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0040-4020(02)00527-6"
                ]
            }
        },
        "BIBREF22": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Holy",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Rev Drug Discov",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/nrd1877"
                ]
            }
        },
        "BIBREF23": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Karplus",
                    "suffix": ""
                }
            ],
            "year": 1963,
            "venue": "J Am Chem Soc",
            "volume": "85",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja00901a059"
                ]
            }
        },
        "BIBREF24": {
            "title": "",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Benezra",
                    "suffix": ""
                }
            ],
            "year": 1973,
            "venue": "J Am Chem Soc",
            "volume": "95",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja00802a003"
                ]
            }
        },
        "BIBREF25": {
            "title": "",
            "authors": [
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Neeser",
                    "suffix": ""
                },
                {
                    "first": "JMJ",
                    "middle": [],
                    "last": "Tronchet",
                    "suffix": ""
                },
                {
                    "first": "EJ",
                    "middle": [],
                    "last": "Charollais",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Can J Chem",
            "volume": "61",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1139/v83-367"
                ]
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Adiwidjaja",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Meyer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Thiem",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "Z Naturforsch",
            "volume": "34",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1515/znb-1979-1113"
                ]
            }
        },
        "BIBREF27": {
            "title": "",
            "authors": [
                {
                    "first": "GW",
                    "middle": [],
                    "last": "Buchanan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bourque",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Seeley",
                    "suffix": ""
                }
            ],
            "year": 1986,
            "venue": "Magn Res Chem",
            "volume": "24",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/mrc.1260240418"
                ]
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zygmunt",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Walkowiak",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Mastalerz",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "Pol J Chem",
            "volume": "54",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF30": {
            "title": "",
            "authors": [
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Magee",
                    "suffix": ""
                },
                {
                    "first": "DH",
                    "middle": [],
                    "last": "Evans",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Antiviral Res",
            "volume": "96",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2012.08.010"
                ]
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [
                {
                    "first": "IE",
                    "middle": [],
                    "last": "G\u0142owacka",
                    "suffix": ""
                },
                {
                    "first": "DG",
                    "middle": [],
                    "last": "Piotrowska",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Andrei",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Schols",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Snoeck",
                    "suffix": ""
                },
                {
                    "first": "AE",
                    "middle": [],
                    "last": "Wr\u00f3blewski",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Monatsh Chem",
            "volume": "147",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00706-016-1848-x"
                ]
            }
        },
        "BIBREF32": {
            "title": "",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Holm",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bockermann",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Wellner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Baecklund",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Holmdahl",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg Med Chem",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2006.05.023"
                ]
            }
        },
        "BIBREF33": {
            "title": "",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Blomberg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kreye",
                    "suffix": ""
                },
                {
                    "first": "CS",
                    "middle": [],
                    "last": "Fowler",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brickmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Org Biomol Chem",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/b515618a"
                ]
            }
        },
        "BIBREF34": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hedenstr\u00f6m",
                    "suffix": ""
                },
                {
                    "first": "ZQ",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brickmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Carlsson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ekholm",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Johansson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kreutz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nilsson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Sethson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Med Chem",
            "volume": "45",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm011073b"
                ]
            }
        },
        "BIBREF35": {
            "title": "",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hol\u00fd",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Curr Pharm Des",
            "volume": "9",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.2174/1381612033453668"
                ]
            }
        }
    }
}